BIO 2026: Cell and gene therapy firms outline their use of AI in manufacturing - Pharmaceutical Technology

From data lakes to streamlined production, Kriya, Opus, and Epicrispr discuss how technology is improving their operations. From data lakes to streamlined production, Kriya, Opus, and Epicrispr discuss how technology is improving their operations. Companies are exploring the use of artificial intelligence (AI) in vector design, data analysis and other key steps of the cell and gene therapy manufacturing process. Image credit: [Gorodenkoff]/Shutterstock.com Complexity is inherent to cell and gene therapy and that includes its manufacturing, where moving towards producing products at a commercial scale continues to challenge companies in the sector. To improve their operations, many firms are looking…

Source: Pharmaceutical Technology